Tumor Budding as a Histologic Prognostic Parameter in Oral Squamous Cell Carcinoma: Comparison of Scoring Systems and Rationale for the Use of Immunohistochemistry [0.03%]
舌鳞状细胞癌的肿瘤芽生作为组织学预后参数：评分系统对比及免疫组化使用的合理性探讨
Akhila Gopakumar,Smriti Panda,Rajeev Kumar Malhotra et al.
Akhila Gopakumar et al.
Context.—: Tumor budding (TB) is associated with nodal metastasis and worse outcomes in oral squamous cell carcinoma. However, there is a need for standardization of its assessment. ...
Embryonal Carcinoma Involving the Ovary: A Morphologic Study of 55 Tumors Almost Never Pure, But Common Within Malignant Mixed Germ Cell Tumors [0.03%]
胚胎癌累及卵巢：55例罕见单纯型而常见于恶性混合性生殖细胞肿瘤中的形态学研究
Valentina Zanfagnin,Esther Oliva,Robert H Young
Valentina Zanfagnin
Context.—: Embryonal carcinoma (ECA) of the ovary is rare, particularly in pure form, with very limited available information. Objective.—: ...
Philip J Katzman,Heather B Florescue,Rachelle P Mendoza et al.
Philip J Katzman et al.
Context.—: Two recurring themes in placental pathology include (1) the difficulty clinicians have in reading placenta pathology reports; and (2) the irrelevance that many diagnoses have in clinical practice. ...
Endometriosis-Associated Neoplasms: A Review of Clinicopathologic Features and Common Diagnostic Challenges [0.03%]
子宫内膜异位症相关肿瘤：临床病理特征及常见诊断挑战综述
Joy M Hoang,Ramya P Masand
Joy M Hoang
Context.—: Neoplastic potential of endometriosis is well established, albeit rare, and endometriosis-associated neoplasms are frequently encountered in clinical practice. ...
Adherence to the American Society of Clinical Oncology/College of American Pathologists Guideline for Reporting Cold Ischemia Time and Breast Formalin Fixation Is Easier Said Than Done [0.03%]
遵循美国临床肿瘤学会/美国病理学家学院关于报道低温缺血时间和乳腺甲醛固定的标准方案说起来容易做起来难
Michael A Balatico,Sumie Edwards,Rachel E Factor
Michael A Balatico
Factors Influencing Choice of Laboratory-Developed Tests and US Food and Drug Administration (FDA)-Approved or FDA-Cleared In Vitro Diagnostics for Molecular Analytes [0.03%]
影响选择实验室研发检验与美国食品药品监督管理局(FDA)批准或认可的分子检测试验的因素分析
Benjamin F Smith,Julia A Bridge,Susan J Hsiao et al.
Benjamin F Smith et al.
Context.—: Clinical laboratory tests in the United States have been subject to dichotomous regulatory oversight, encompassing both laboratory-developed tests (LDTs) and US Food and Drug Administration (FDA)-approved or F...
Interrater Variability in the Application of the Goldman Criteria to Medical Autopsies [0.03%]
戈尔德曼标准在医学尸体检验中的评判差异性
Meagan Chambers,Tanner Bartholow,Thomas Long et al.
Meagan Chambers et al.
Context.—: The Goldman criteria are widely used to categorize diagnostic discrepancies in autopsy reports for hospital quality assurance. Despite their adoption, little is known about how consistently they are applied ac...
Mixed Neuroendocrine-Nonneuroendocrine Neoplasms of the Pancreas: Unraveling the Concept and Applying It to Clinical Practice [0.03%]
胰腺混合型神经内分泌肿瘤的概念及其临床应用
David S Klimstra
David S Klimstra
Context.—: Although most pancreatic epithelial neoplasms show differentiation predominantly along ductal, neuroendocrine, or acinar lines, minor elements with divergent differentiation are common, and some neoplasms have...
Performance Verification and Establishment of Reference Intervals for Dendritic Cells, γδT Cells, and Follicular Helper T Cells Using Flow Cytometry [0.03%]
流式细胞术检测树突状细胞、γδT 细胞和滤泡辅助性 T 细胞的性能验证及参考区间建立
Mei Liu,Tian-Ling Yang,Xin Cheng et al.
Mei Liu et al.
Context.—: Dendritic cells (DCs), gamma-delta T (γδT) cells, and T follicular helper (Tfh) cells are key players in immune responses and clinical surveillance. While flow cytometry (FCM) provides precise quantification...
Breast Cancers With Discordant Human Epidermal Growth Factor Receptor 2 Fluorescence In Situ Hybridization-Positive (Group 1) and Immunohistochemistry-Negative (0/1+) Results Following American Society of Clinical Oncology/College of American Pathologists Guideline [0.03%]
美国临床肿瘤学会/病理学院指南发布后HER2荧光原位杂交阳性(I型)和免疫组化阴性(0/1+)不一致的乳腺癌
Diane Wilcock,Jolanta Jedrzkiewicz,Allison S Cleary et al.
Diane Wilcock et al.
Context.—: Immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) have been widely used for human epidermal growth factor receptor 2 (HER2) status determination in breast cancers for about 25 years. Mos...